Brief: Immutep’S Efti In Combination With Keytruda Generates Excellent Overall Survival Benefit
23/10/2023 13:16
Oct 23 (Reuters) - Immutep Ltd IMM.AX :
* IMMUTEP’S EFTI IN COMBINATION WITH KEYTRUDA GENERATES
EXCELLENT
OVERALL SURVIVAL BENEFIT IN PATIENTS WITH METASTATIC NON-SMALL
CELL LUNG CANCER
Source text for Eikon: ID:nGNX6TWLBj
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))